TY - JOUR
T1 - Evaluation of the impact of anaemia on quality of life among breast cancer patients undergoing chemotherapy in Malaysia
AU - Muthanna, Fares Mohammed Saeed
AU - Hassan, Bassam Abdul Rasool
AU - Karuppannan, Mahmathi
AU - Mohammed, Ali Haider
N1 - Publisher Copyright:
© The Author(s) 2021. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved.
PY - 2021/6
Y1 - 2021/6
N2 - Objectives The purpose of this study was to evaluate the impact of anaemia on the quality of life (QOL) among breast cancer patients. Methods A total of 120 anaemic (haemoglobin < 12 g/dL) breast cancer patients were identified through chart review. Patients were followed-up for three cycles of chemotherapy filled in a QOL questionnaire Functional Assessment Chronic Therapy -Anaemia at each follow-up session. Data such as haemoglobin Hb levels and chemotherapy regimens were also recorded on each follow-up. Data were analysed using SPSS. Key findingsThe Hb level and QOL mean scores of all follow-ups were 10.34 ± 0.73 g/dL and 96.37 ± 16.15 g/dL, respectively. QOL was adversely affected by anaemia severity, and the curves declined significantly from the first follow-up to the third follow-up (P < 0.001). Conclusion It is crucial to consider developing a guideline for the treatment of anaemia, which is not available currently, and improve the QOL for the wellbeing of cancer patients.
AB - Objectives The purpose of this study was to evaluate the impact of anaemia on the quality of life (QOL) among breast cancer patients. Methods A total of 120 anaemic (haemoglobin < 12 g/dL) breast cancer patients were identified through chart review. Patients were followed-up for three cycles of chemotherapy filled in a QOL questionnaire Functional Assessment Chronic Therapy -Anaemia at each follow-up session. Data such as haemoglobin Hb levels and chemotherapy regimens were also recorded on each follow-up. Data were analysed using SPSS. Key findingsThe Hb level and QOL mean scores of all follow-ups were 10.34 ± 0.73 g/dL and 96.37 ± 16.15 g/dL, respectively. QOL was adversely affected by anaemia severity, and the curves declined significantly from the first follow-up to the third follow-up (P < 0.001). Conclusion It is crucial to consider developing a guideline for the treatment of anaemia, which is not available currently, and improve the QOL for the wellbeing of cancer patients.
KW - Anaemia
KW - Breast cancer
KW - Chemotherapy
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85110949135&partnerID=8YFLogxK
U2 - 10.1093/jphsr/rmaa033
DO - 10.1093/jphsr/rmaa033
M3 - Article
AN - SCOPUS:85110949135
SN - 1759-8885
VL - 12
SP - 310
EP - 312
JO - Journal of Pharmaceutical Health Services Research
JF - Journal of Pharmaceutical Health Services Research
IS - 2
ER -
